.png){kind=icon}
XcellerateTechnology Suite
Xcellerate®is a suite of data and technology enabling solutions designed to increase drug and medical device development efficiency, reduce timelines, improve compliance, and drive commercialization.
SERVICES
Data and Technology
Covance utilizes unrivaled, proprietary data and technology to improve clinical study outcomes.
By the Numbers
网站激活病人
4.2
Months Faster vs. The Industry Oncology - Global - Phase I-IV
Recruitment Rate
14%
Faster vs. The Industry Oncology - Global - Phase I-IV
Screen Failure
26%
Fewer vs. The Industry Oncology - Global - Phase I-IV
Patient Density
63%
Better vs. The Industry Cardiology - Global - Phase I-IV
FEATURED WEBINAR
Measuring Success of a Quality Risk Management Approach
一个s regulatory guidance and data collection in clinical trials has evolved, sponsors face pressure to balance quality, productivity and cost for risk management and monitoring. The industry has adopted risk-based quality management (RBQM), yet the methodology is inconsistent. There is no standard way to measure the impact of the different approaches to RBQM on the effectiveness of clinical trial management. Learn more about our approach to establishing and tracking metrics – including those that could apply across the industry – to measure the success of an RBQM approach.
TESTIMONIAL
"Nobody on the market has this depth of insights related to why patients would/would not join a clinical trial. This is a differentiator and extremely innovative.”
–VP, Top 5 Pharma
REQUEST A DEMO
Increase the efficiency and effectiveness of your clinical trials with Xcellerate
Learn More
Covance by Labcorp is a leading global life sciences company, which provides contract research services to the drug, medical device and diagnostics, crop protection and chemical industries.
COVANCE is a registered trademark and the marketing name for Covance Inc. and its subsidiaries around the world.